Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content

Protect with confidence1 your patient's healthy parathyroid tissue — and their quality of life2

PTeye™ parathyroid detection system

The PTeye™ parathyroid detection system is an intra-operative probe-based technology to aid you in confirming suspected parathyroid tissue during thyroid and parathyroid surgery.3

Up to 22% of thyroid surgeries result in incidental parathyroid removal.4 This puts patients at risk for hypoparathyroidism — a condition associated with a number of short- and long-term complications.2,5-9

PTeye parathyroid detection system


up to

96%
accuracy3

 

Real-time confirmation

Add to your visual identification of the parathyroid gland with PTeye™ parathyroid detection system, providing real-time confirmation with up to 96% accuracy.3

PTeye™ parathyroid system is based on an intraoperative technique that uses near-infared (NIR) autoflourescence for in vivo, real-time confirmation of visually suspected parathyroid tissue.3

PTeye parathyroid detection system

Identify with confidence

 

88.9%

Confirming parathyroid gland tissue in 88.9% (24/27) of the cases1

When identified with medium confidence, PTeye™ was highly beneficial for further improving the surgeon's confidence and confirming PG tissue in 88.9% (24/27) of cases¹

 

7.4%

Prevented surgeon error in
7.4% (2/27) of times1

When identified with medium confidence, PTeye™ was highly beneficial for further improving the surgeon's confidence and preventing surgeon error in 7.4% (2/27).¹


Surgeons reported improved confidence in identifying parathyroid glands by using PTeye™1

In a study, surgeons reported that using the PTeye™ system improved confidence in identifying the parathyroid gland, regardless of the experience.¹

KOL voices

Discover what your peers say about the importance of the parathyroid detection and the Medtronic PTeye™ parathyroid detection system.

Dr. Solorzano

Carmen C. Solórzano, M.D., FACS

Get in contact and discover the PTeye™ parathyroid detection system

Learn more about the PTeye™ system live with your Medtronic representative during a product demonstration. By submitting the form, we will get a notification to reach out to you. We are looking forward to introducing this new technology to you.

*Indicates Required Field

Your information will be processed and protected in accordance with our privacy statement

Selecting “no” to marketing emails above will not affect your other email selections, and a Medtronic representative will still reach out via email, if selected. Your personal data will used to manage your relationship with Medtronic, and, if you consent, to provide you with relevant email updates based on your user preferences. You can opt-out of receiving such emails at any time by clicking the unsubscribe link in the relevant email. Medtronic may use pixels and other technologies in emails to gather statistics around email opening and clicks, to help us improve our communications and to provide you with relevant content. For more information, see the Medtronic privacy notice.

You can always change your preferences or update your personal details by visiting the Preference center.

See the Preference center

1

Kiernan CM, Thomas G, Baregamian N, Solόrzano CC. Initial clinical experiences using the intraoperative probe-based parathyroid autofluorescence identification system - PTeye™ during thyroid and parathyroid procedures. J Surg Oncol. 2021;124:271–281.

2

Siggelkow, H, Clarke, BL, Germak, J, et al. Burden of illness in not adequately controlled chronic hypoparathyroidism: Findings from a 13-country patient and caregiver survey. Clin Endocrinol (Oxy), 2020; 92: 159–168. doi: 10.1111/cen.14128. Epub 2019 Dec 11. PMID: 31721256; PMCID: PMC7027891.

3

PTeye IFU M012700C001

4

Applewhite M. et al Incidence, Risk Factors, and Clinical Outcomes of Incidental Parathyroidectomy During Thyroid Surgery, Ann Surg Oncol 2016 Dec; 23(13):4310–4315. doi: 10.1245/s10434-016-5439-1. Epub 2016 Aug 19. PMID: 27541813.

5

Büttner M, Singer S, Taylor K. Quality of life in patients with hypoparathyroidism receiving standard treatment: an updated systematic review. Endocrine. 2024 Apr 5. doi: 10.1007/s12020-024-03807-2. Epub ahead of print. PMID: 38578400.

6

Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res. 2013 Nov;28(11):2277–85. doi: 10.1002/jbmr.1979. PMID: 23661265.

7

Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Postsurgical hypoparathyroidism--risk of fractures, psychiatric diseases, cancer, cataract, and infections. J Bone Miner Res. 2014 Nov;29(11):2504–10. doi: 10.1002/jbmr.2273. PMID: 24806578

8

Underbjerg L, Sikjaer T, Rejnmark L. Long-Term Complications in Patients With Hypoparathyroidism Evaluated by Biochemical Findings: A Case-Control Study. J Bone Miner Res. 2018 May;33(5):822–831. doi: 10.1002/jbmr.3368. Epub 2018 Feb 14. PMID: 29281760.

9

Gosmanova EO, Chen K, Ketteler M, et al. Risk of Cardiovascular Conditions in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study. Adv Ther. 2021 Aug;38(8):4246–4257. doi: 10.1007/s12325-021-01787-7. Epub 2021 Jun 24. PMID: 34165700; PMCID: PMC8342323.

See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.